The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.10 - Manufacture of basic pharmaceutical products
400 jobs Number of planned job losses
Announcement Date
11 January 2023
Employment effect (start)
1 September 2023
Foreseen end date
1 April 2024
Description
As part of its global reorganisation plan to reduce its workforce by 7%, or 8,000 jobs worldwide, the pharmaceutical group Novartis has announced it will cut around 400 jobs in France from its current 2,900 total. The global reorganisation consists of Novartis' merging its historical Pharmaceutical and Oncology divisions into a single Innovative Medicines division. The two production sites located in Huningue (Alsace) and Les Ulis (Essonne) will not be affected. The workforce reductions are concentrated at the headquarters in Rueil-Malmaison (Haut-de-Seine), which has 1,400 employees, due to the merger of the two divisions. If the 400 job cuts are confirmed after the consultation phase with staff representatives, the reduction in the workforce will be 14% for France, which is double the worldwide average for the reorganisation plan.
A previous reorganisation was recorded in the ERM Database in 2008 with 100 job losses (FR-Novartis-2008).
Eurofound (2023), Novartis, Internal restructuring in France, factsheet number 108183, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/108183.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...